메뉴 건너뛰기




Volumn 6, Issue 1, 2007, Pages 2-8

Interstitial implant alone or in combination with external beam radiation therapy for intermediate-risk prostate cancer: A survey of practice patterns in the United States

(21)  Frank, Steven J a   Grimm, Peter D b   Sylvester, John E b   Merrick, Gregory S c   Davis, Brian J d   Zietman, Anthony e   Moran, Brian J f   Beyer, David C g   Roach III, Mack h   Clarke, Daniel H i   Stock, Richard G j   Robert Lee, W k   Michalski, Jeff M l   Wallner, Kent E m   Hurwitz, Mark n   Potters, Louis o   Kuban, Deborah A a   Prestidge, Bradley R p   Vera, Robyn b   Hathaway, Shannon b   more..


Author keywords

Brachytherapy; Intermediate risk; Prostate

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

EID: 33846599235     PISSN: 15384721     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brachy.2006.09.004     Document Type: Article
Times cited : (49)

References (26)
  • 1
    • 0030778649 scopus 로고    scopus 로고
    • Brachytherapy for clinically localized prostate cancer: Results at 7- and 8-year follow-up
    • Ragde H., Blasko J.C., Grimm P.D., et al. Brachytherapy for clinically localized prostate cancer: Results at 7- and 8-year follow-up. Semin Surg Oncol 13 (1997) 438-443
    • (1997) Semin Surg Oncol , vol.13 , pp. 438-443
    • Ragde, H.1    Blasko, J.C.2    Grimm, P.D.3
  • 2
    • 0030728276 scopus 로고    scopus 로고
    • The history of interstitial brachytherapy of prostatic cancer
    • Holm H.H. The history of interstitial brachytherapy of prostatic cancer. Semin Surg Oncol 13 (1997) 431-437
    • (1997) Semin Surg Oncol , vol.13 , pp. 431-437
    • Holm, H.H.1
  • 3
    • 0029112632 scopus 로고
    • Prostate specific antigen based disease control following ultrasound guided 125iodine implantation for stage T1/T2 prostatic carcinoma
    • Blasko J.C., Wallner K., Grimm P.D., et al. Prostate specific antigen based disease control following ultrasound guided 125iodine implantation for stage T1/T2 prostatic carcinoma. J Urol 154 (1995) 1096-1099
    • (1995) J Urol , vol.154 , pp. 1096-1099
    • Blasko, J.C.1    Wallner, K.2    Grimm, P.D.3
  • 4
    • 3042613335 scopus 로고    scopus 로고
    • Changing trends in national practice for external beam radiotherapy for clinically localized prostate cancer: 1999 Patterns of Care survey for prostate cancer
    • Zelefsky M.J., Moughan J., Owen J., et al. Changing trends in national practice for external beam radiotherapy for clinically localized prostate cancer: 1999 Patterns of Care survey for prostate cancer. Int J Radiat Oncol Biol Phys 59 (2004) 1053-1061
    • (2004) Int J Radiat Oncol Biol Phys , vol.59 , pp. 1053-1061
    • Zelefsky, M.J.1    Moughan, J.2    Owen, J.3
  • 5
    • 0036618196 scopus 로고    scopus 로고
    • Permanent seed implantation for localized adenocarcinoma of the prostate
    • Stone N.N., and Stock R.G. Permanent seed implantation for localized adenocarcinoma of the prostate. Curr Urol Rep 3 (2002) 201-206
    • (2002) Curr Urol Rep , vol.3 , pp. 201-206
    • Stone, N.N.1    Stock, R.G.2
  • 6
    • 0030764130 scopus 로고    scopus 로고
    • Interstitial iodine-125 radiation without adjuvant therapy in the treatment of clinically localized prostate carcinoma
    • Ragde H., Blasko J.C., Grimm P.D., et al. Interstitial iodine-125 radiation without adjuvant therapy in the treatment of clinically localized prostate carcinoma. Cancer 80 (1997) 442-453
    • (1997) Cancer , vol.80 , pp. 442-453
    • Ragde, H.1    Blasko, J.C.2    Grimm, P.D.3
  • 7
    • 0032538069 scopus 로고    scopus 로고
    • Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer
    • D'Amico A.V., Whittington R., Malkowicz S.B., et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 280 (1998) 969-974
    • (1998) JAMA , vol.280 , pp. 969-974
    • D'Amico, A.V.1    Whittington, R.2    Malkowicz, S.B.3
  • 8
    • 0030913315 scopus 로고    scopus 로고
    • Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update
    • Partin A.W., Kattan M.W., Subong E.N., et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA 277 (1997) 1445-1451
    • (1997) JAMA , vol.277 , pp. 1445-1451
    • Partin, A.W.1    Kattan, M.W.2    Subong, E.N.3
  • 9
    • 0033047030 scopus 로고    scopus 로고
    • American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer
    • Nag S., Beyer D., Friedland J., et al. American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer. Int J Radiat Oncol Biol Phys 44 (1999) 789-799
    • (1999) Int J Radiat Oncol Biol Phys , vol.44 , pp. 789-799
    • Nag, S.1    Beyer, D.2    Friedland, J.3
  • 10
    • 0035192666 scopus 로고    scopus 로고
    • Clinical selection issues for permanent seed prostate brachytherapy
    • Grimm P.B.J., and Sylvester J. Clinical selection issues for permanent seed prostate brachytherapy. J Brachyther Int 17 (2001) 143-152
    • (2001) J Brachyther Int , vol.17 , pp. 143-152
    • Grimm, P.B.J.1    Sylvester, J.2
  • 11
    • 17144368838 scopus 로고    scopus 로고
    • 12-year outcomes following permanent prostate brachytherapy in patients with clinically localized prostate cancer
    • Potters L., Morgenstern C., Calugaru E., et al. 12-year outcomes following permanent prostate brachytherapy in patients with clinically localized prostate cancer. J Urol 173 (2005) 1562-1566
    • (2005) J Urol , vol.173 , pp. 1562-1566
    • Potters, L.1    Morgenstern, C.2    Calugaru, E.3
  • 12
    • 11144347632 scopus 로고    scopus 로고
    • Impact of supplemental external beam radiotherapy and/or androgen deprivation therapy on biochemical outcome after permanent prostate brachytherapy
    • Merrick G.S., Butler W.M., Wallner K.E., et al. Impact of supplemental external beam radiotherapy and/or androgen deprivation therapy on biochemical outcome after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 161 (2005) 32-43
    • (2005) Int J Radiat Oncol Biol Phys , vol.161 , pp. 32-43
    • Merrick, G.S.1    Butler, W.M.2    Wallner, K.E.3
  • 13
    • 0036294273 scopus 로고    scopus 로고
    • Biochemical outcome for hormone-naive patients with Gleason score 3 + 4 versus 4 + 3 prostate cancer undergoing permanent prostate brachytherapy
    • Merrick G.S., Butler W.M., Galbreath R.W., et al. Biochemical outcome for hormone-naive patients with Gleason score 3 + 4 versus 4 + 3 prostate cancer undergoing permanent prostate brachytherapy. Urology 60 (2002) 98-103
    • (2002) Urology , vol.60 , pp. 98-103
    • Merrick, G.S.1    Butler, W.M.2    Galbreath, R.W.3
  • 14
    • 0036498873 scopus 로고    scopus 로고
    • Relationship between percent positive biopsies and biochemical outcome after permanent interstitial brachytherapy for clinically organ-confined carcinoma of the prostate gland
    • Merrick G.S., Butler W.M., Galbreath R.W., et al. Relationship between percent positive biopsies and biochemical outcome after permanent interstitial brachytherapy for clinically organ-confined carcinoma of the prostate gland. Int J Radiat Oncol Biol Phys 52 (2002) 664-673
    • (2002) Int J Radiat Oncol Biol Phys , vol.52 , pp. 664-673
    • Merrick, G.S.1    Butler, W.M.2    Galbreath, R.W.3
  • 15
    • 0036359308 scopus 로고    scopus 로고
    • Perineural invasion is not predictive of biochemical outcome following prostate brachytherapy
    • Merrick G.S., Butler W.M., Galbreath R.W., et al. Perineural invasion is not predictive of biochemical outcome following prostate brachytherapy. Cancer J 8 (2002) 79-80
    • (2002) Cancer J , vol.8 , pp. 79-80
    • Merrick, G.S.1    Butler, W.M.2    Galbreath, R.W.3
  • 16
    • 0141892573 scopus 로고    scopus 로고
    • Myths and fallacies in permanent prostate brachytherapy
    • Butler W.M., and Merrick G.S. Myths and fallacies in permanent prostate brachytherapy. Med Dosim 28 (2003) 155-165
    • (2003) Med Dosim , vol.28 , pp. 155-165
    • Butler, W.M.1    Merrick, G.S.2
  • 17
    • 4644225078 scopus 로고    scopus 로고
    • Impact of the percentage of positive prostate cores on prostate cancer-specific mortality for patients with low or favorable intermediate-risk disease
    • D'Amico A.V., Renshaw A.A., Cote K., et al. Impact of the percentage of positive prostate cores on prostate cancer-specific mortality for patients with low or favorable intermediate-risk disease. Am J Clin Oncol 22 (2004) 3726-3732
    • (2004) Am J Clin Oncol , vol.22 , pp. 3726-3732
    • D'Amico, A.V.1    Renshaw, A.A.2    Cote, K.3
  • 18
    • 0036837489 scopus 로고    scopus 로고
    • Percentage of positive biopsy cores as predictor of clinical outcome in prostate cancer treated with radiotherapy
    • Kestin L.L., Goldstein N.S., Vicini F.A., et al. Percentage of positive biopsy cores as predictor of clinical outcome in prostate cancer treated with radiotherapy. J Urol 168 (2002) 1994-1999
    • (2002) J Urol , vol.168 , pp. 1994-1999
    • Kestin, L.L.1    Goldstein, N.S.2    Vicini, F.A.3
  • 19
    • 31944436965 scopus 로고    scopus 로고
    • Percentage of positive biopsies associated with freedom from biochemical recurrence after low-dose-rate prostate brachytherapy alone for clinically localized prostate cancer
    • Rossi P.J., Clark P.E., Papagikos M.A., et al. Percentage of positive biopsies associated with freedom from biochemical recurrence after low-dose-rate prostate brachytherapy alone for clinically localized prostate cancer. Urology 67 (2006) 349-353
    • (2006) Urology , vol.67 , pp. 349-353
    • Rossi, P.J.1    Clark, P.E.2    Papagikos, M.A.3
  • 20
    • 0031873864 scopus 로고    scopus 로고
    • The role of perineural invasion and other biopsy characteristics as prognostic markers for localized prostate cancer
    • Epstein J.I. The role of perineural invasion and other biopsy characteristics as prognostic markers for localized prostate cancer. Semin Surg Oncol 16 (1998) 124-128
    • (1998) Semin Surg Oncol , vol.16 , pp. 124-128
    • Epstein, J.I.1
  • 21
    • 0035463592 scopus 로고    scopus 로고
    • Perineural invasion as a predictor of PSA outcome following local therapy for patients with clinically localized prostate cancer
    • D'Amico A.V. Perineural invasion as a predictor of PSA outcome following local therapy for patients with clinically localized prostate cancer. Cancer J 7 (2001) 375-376
    • (2001) Cancer J , vol.7 , pp. 375-376
    • D'Amico, A.V.1
  • 22
    • 0038281332 scopus 로고    scopus 로고
    • The prognostic significance of Gleason Grade in patients treated with permanent prostate brachytherapy
    • Potters L., Purrazzella R., Brustein S., et al. The prognostic significance of Gleason Grade in patients treated with permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 56 (2003) 749-754
    • (2003) Int J Radiat Oncol Biol Phys , vol.56 , pp. 749-754
    • Potters, L.1    Purrazzella, R.2    Brustein, S.3
  • 23
    • 0032725113 scopus 로고    scopus 로고
    • The impact of the biopsy Gleason score on PSA outcome for prostate cancer patients with PSA < or = 10 ng/ml and T1c, 2a: Implications for patient selection for prostate-only therapy
    • D'Amico A.V., Renshaw A.A., Schultz D., et al. The impact of the biopsy Gleason score on PSA outcome for prostate cancer patients with PSA < or = 10 ng/ml and T1c, 2a: Implications for patient selection for prostate-only therapy. Int J Radiat Oncol Biol Phys 45 (1999) 847-857
    • (1999) Int J Radiat Oncol Biol Phys , vol.45 , pp. 847-857
    • D'Amico, A.V.1    Renshaw, A.A.2    Schultz, D.3
  • 24
    • 0035024926 scopus 로고    scopus 로고
    • Primary Gleason pattern as a predictor of disease progression in Gleason score 7 prostate cancer: A multivariate analysis of 823 men treated with radical prostatectomy
    • Herman C.M., Kattan M.W., Ohori M., et al. Primary Gleason pattern as a predictor of disease progression in Gleason score 7 prostate cancer: A multivariate analysis of 823 men treated with radical prostatectomy. Am J Surg Pathol 25 (2001) 657-660
    • (2001) Am J Surg Pathol , vol.25 , pp. 657-660
    • Herman, C.M.1    Kattan, M.W.2    Ohori, M.3
  • 25
    • 0038406126 scopus 로고    scopus 로고
    • External radiotherapy and permanent prostate brachytherapy in patients with localized prostate cancer
    • Potters L., Fearn P., and Kattan M.W. External radiotherapy and permanent prostate brachytherapy in patients with localized prostate cancer. Brachytherapy 1 (2002) 36-41
    • (2002) Brachytherapy , vol.1 , pp. 36-41
    • Potters, L.1    Fearn, P.2    Kattan, M.W.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.